Cargando…

IgM-enriched immunoglobulin in COVID-19: Case series of 15 severely ill SARS-CoV-2-infected patients

The healthcare system in Iran, like most around the world, is managing thousands of patients hospitalised with COVID-19. In Iran, in-hospital mortality is in the region of 25%, rising to 50–60% in patients admitted to intensive care. Hyperinflammation, characterised by cytokine storm, appears to be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabarsi, Payam, Hashemian, Seyed Mohammad Reza, Bauhofer, Artur, Savadkoohi, Ali Amir, Ghadimi, Somayeh, Haseli, Sara, Dastan, Farzaneh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299233/ https://www.ncbi.nlm.nih.gov/pubmed/34315117 http://dx.doi.org/10.1016/j.intimp.2021.107998

Ejemplares similares

Clinical efficacy of IgM-enriched immunoglobulin as adjunctive therapy in neonatal and pediatric sepsis: a systematic review and meta-analysis
por: Dinleyici, Ener Cagri, et al.
Publicado: (2023)

Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial
por: Barati, Saghar, et al.
Publicado: (2021)

IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices
por: Immohr, Moritz Benjamin, et al.
Publicado: (2022)

Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin
por: Immohr, Moritz Benjamin, et al.
Publicado: (2021)

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin
por: Bohländer, Fabian, et al.
Publicado: (2021)

Are IgM-enriched immunoglobulins an effective adjuvant in septic VLBW infants?
por: Capasso, Letizia, et al.
Publicado: (2013)

Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis
por: Nierhaus, Axel, et al.
Publicado: (2020)

A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol
por: Jamaati, Hamidreza, et al.
Publicado: (2020)

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
por: Tabarsi, Payam, et al.
Publicado: (2021)

Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers
por: Scarpati, Giuliana, et al.
Publicado: (2021)

The Role of IgM-Enriched Immunoglobulin (Pentaglobin) in Septic Patients with Hematological Disease
por: Fernandes, Pedro Amoedo, et al.
Publicado: (2021)

The Role of the Intravenous IgA and IgM-Enriched Immunoglobulin Preparation in the Treatment of Sepsis and Septic Shock
por: Berlot, Giorgio, et al.
Publicado: (2023)

The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]
por: Tugrul, Simru, et al.
Publicado: (2002)

Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Tocilizumab administration in a refractory case of COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view
por: Karatzas, Stylianos, et al.
Publicado: (2002)

IgM-enriched immunoglobulin improves colistin efficacy in a pneumonia model by Pseudomonas aeruginosa
por: Cebrero-Cangueiro, Tania, et al.
Publicado: (2022)

Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients
por: Berlot, Giorgio, et al.
Publicado: (2018)

Kinetics of Immunoglobulins in Septic Shock Patients Treated With an IgM- and IgA-Enriched Intravenous Preparation: An Observational Study
por: Berlot, Giorgio, et al.
Publicado: (2021)

The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System
por: Schmidt, Carolin, et al.
Publicado: (2021)

IgM-enriched immunoglobulins (Pentaglobin) may improve the microcirculation in sepsis: a pilot randomized trial
por: Domizi, Roberta, et al.
Publicado: (2019)

Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis
por: Wei, Hao, et al.
Publicado: (2021)

Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial)
por: Biagioni, Emanuela, et al.
Publicado: (2021)

Correction to: Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients
por: Berlot, Giorgio, et al.
Publicado: (2019)

Preemptive treatment of early donor‐specific antibodies with IgA‐ and IgM‐enriched intravenous human immunoglobulins in lung transplantation
por: Ius, Fabio, et al.
Publicado: (2018)

Tocilizumab as a promising agent against COVID-19: Issues and challenges
por: Dastan, Farzaneh, et al.
Publicado: (2021)

Late Post-Coronavirus Disease 2019 Inflammatory Syndrome: A Case Experience with Tocilizumab
por: Tabarsi, Payam, et al.
Publicado: (2021)

No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial
por: Jamaati, Hamidreza, et al.
Publicado: (2021)

The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view – authors' response
por: Tugrul, Simru
Publicado: (2002)

Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study
por: Rahmel, Tim, et al.
Publicado: (2022)

Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
por: Baghaei, Parvaneh, et al.
Publicado: (2021)

IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study
por: Wand, Saskia, et al.
Publicado: (2016)

A human IgM enriched immunoglobulin preparation, Pentaglobin, reverses autoimmune diabetes without immune suppression in NOD mice
por: Wilson, Christopher S., et al.
Publicado: (2022)

Oxygenation Efforts for Iranian COVID-19 ARDS Patients: First 5-Day Crisis Experience Scenario
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2020)

Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Influence of an immunoglobulin-enriched (IgG, IgA, IgM) solution on activation and immunomodulatory functions of peripheral blood mononuclear cells in a LPS second-hit model
por: Duerr, C, et al.
Publicado: (2011)

The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis
por: Cui, Jie, et al.
Publicado: (2019)

Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children
por: BAYRAM, Rumeysa Olcay, et al.
Publicado: (2019)

MEMBRANE IMMUNOGLOBULINS OF B LYMPHOCYTES : Inability to Detect Certain Characteristic IgM and IgD Antigens
por: Fu, S. M., et al.
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_1kfe0gf5agl78l8rqcb8648o25